These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28351936)

  • 1. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.
    Dourado KMC; Baik J; Oliveira VKP; Beltrame M; Yamamoto A; Theuer CP; Figueiredo CAV; Verneris MR; Perlingeiro RCR
    Blood; 2017 May; 129(18):2526-2536. PubMed ID: 28351936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
    Lo TH; Abadir E; Gasiorowski RE; Kabani K; Ramesh M; Orellana D; Fromm PD; Kupresanin F; Newman E; Cunningham I; Hart DNJ; Silveira PA; Clark GJ
    PLoS One; 2019; 14(5):e0216368. PubMed ID: 31075107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
    Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
    Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of TRC105 and decitabine combination in AML xenografts.
    Baik J; Felices M; Yingst A; Theuer CP; Verneris MR; Miller JS; Perlingeiro R
    Heliyon; 2020 Oct; 6(10):e05242. PubMed ID: 33088975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
    Fatehchand K; McMichael EL; Reader BF; Fang H; Santhanam R; Gautam S; Elavazhagan S; Mehta P; Buteyn NJ; Merchand-Reyes G; Vasu S; Mo X; Benson DM; Blachly JS; Carson WE; Byrd JC; Butchar JP; Tridandapani S
    J Biol Chem; 2016 Dec; 291(49):25656-25666. PubMed ID: 27780867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
    Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
    J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
    Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
    Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
    Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
    Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
    Ågerstam H; Karlsson C; Hansen N; Sandén C; Askmyr M; von Palffy S; Högberg C; Rissler M; Wunderlich M; Juliusson G; Richter J; Sjöström K; Bhatia R; Mulloy JC; Järås M; Fioretos T
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10786-91. PubMed ID: 26261316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias.
    Chakhachiro ZI; Zuo Z; Aladily TN; Kantarjian HM; Cortes JE; Alayed K; Nguyen MH; Medeiros LJ; Bueso-Ramos C
    Am J Clin Pathol; 2013 Sep; 140(3):370-8. PubMed ID: 23955456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD16
    Williams BA; Wang XH; Leyton JV; Maghera S; Deif B; Reilly RM; Minden MD; Keating A
    Haematologica; 2018 Oct; 103(10):1720-1729. PubMed ID: 29976748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells.
    Furukawa Y; DeCaprio JA; Belvin M; Griffin JD
    Oncogene; 1991 Aug; 6(8):1343-6. PubMed ID: 1886710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells.
    Wu HW; Sheard MA; Malvar J; Fernandez GE; DeClerck YA; Blavier L; Shimada H; Theuer CP; Sposto R; Seeger RC
    Clin Cancer Res; 2019 Aug; 25(15):4761-4774. PubMed ID: 31068371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation.
    Märklin M; Hagelstein I; Hinterleitner C; Salih HR; Kauer J; Heitmann JS
    Int J Hematol; 2020 Jul; 112(1):57-64. PubMed ID: 32266669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression of variant Fas molecules in acute leukemia cells.
    Inaba H; Komada Y; Li QS; Zhang XL; Tanaka S; Azuma E; Yamamoto H; Sakurai M
    Am J Hematol; 1999 Nov; 62(3):150-8. PubMed ID: 10539881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Fc(epsilon)-receptors by human acute myelogenous leukemia (AML) blasts: studies of high- and low- (CD23) affinity receptor expression and the effects of IgE-mediated receptor ligation on functional AML blast characteristics.
    Bruserud Ø; Gjertsen BT; Ulvestad E
    Leuk Res; 2002 May; 26(5):515-21. PubMed ID: 11916528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.
    Mikosik A; Henc I; Ruckemann-Dziurdzińska K; Frąckowiak JE; Płoszyńska A; Balcerska A; Bryl E; Witkowski JM
    PLoS One; 2015; 10(8):e0136615. PubMed ID: 26317226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione in childhood acute leukaemias.
    Kearns P; Pieters R; Rottier MM; Veerman AJ; Schmiegalow K; Pearson AD; Hall AG
    Adv Exp Med Biol; 1999; 457():211-6. PubMed ID: 10500796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.